Accelerating TCE & TCRm Discovery with Diverse & Optimized CD3 Binders
Time: 10:30 am
day: Day 1
Details:
- Diverse and optimized CD3 antibodies are critical to unlocking the full potential of TCE and TCRm therapies
- CD3 affinity, epitope, and signaling strength can be tuned to match the therapeutic application, enabling the development of safer, more effective therapeutics
